Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome
about
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic ReviewBringing attention to a need for a standardized treatment and weaning protocol for neonatal abstinence syndrome.Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant MiceA Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
P2860
Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ondansetron pharmacokinetics i ...... r neonatal abstinence syndrome
@ast
Ondansetron pharmacokinetics i ...... r neonatal abstinence syndrome
@en
type
label
Ondansetron pharmacokinetics i ...... r neonatal abstinence syndrome
@ast
Ondansetron pharmacokinetics i ...... r neonatal abstinence syndrome
@en
prefLabel
Ondansetron pharmacokinetics i ...... r neonatal abstinence syndrome
@ast
Ondansetron pharmacokinetics i ...... r neonatal abstinence syndrome
@en
P2093
P2860
P356
P1476
Ondansetron pharmacokinetics i ...... r neonatal abstinence syndrome
@en
P2093
B Carvalho
D R Drover
J L Galinkin
P2860
P304
P356
10.1002/CPT.5
P407
P577
2014-12-04T00:00:00Z